250 related articles for article (PubMed ID: 15840561)
1. Is prostate-specific membrane antigen a multifunctional protein?
Rajasekaran AK; Anilkumar G; Christiansen JJ
Am J Physiol Cell Physiol; 2005 May; 288(5):C975-81. PubMed ID: 15840561
[TBL] [Abstract][Full Text] [Related]
2. Prostate-specific membrane antigen association with filamin A modulates its internalization and NAALADase activity.
Anilkumar G; Rajasekaran SA; Wang S; Hankinson O; Bander NH; Rajasekaran AK
Cancer Res; 2003 May; 63(10):2645-8. PubMed ID: 12750292
[TBL] [Abstract][Full Text] [Related]
3. Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer.
Ghosh A; Heston WD
J Cell Biochem; 2004 Feb; 91(3):528-39. PubMed ID: 14755683
[TBL] [Abstract][Full Text] [Related]
4. Current application and future perspectives of prostate specific membrane antigen PET imaging in prostate cancer.
Ceci F; Castellucci P; Fanti S
Q J Nucl Med Mol Imaging; 2019 Mar; 63(1):7-18. PubMed ID: 29521482
[TBL] [Abstract][Full Text] [Related]
5. PET imaging of prostate-specific membrane antigen in prostate cancer: current state of the art and future challenges.
Rowe SP; Gorin MA; Allaf ME; Pienta KJ; Tran PT; Pomper MG; Ross AE; Cho SY
Prostate Cancer Prostatic Dis; 2016 Sep; 19(3):223-30. PubMed ID: 27136743
[TBL] [Abstract][Full Text] [Related]
6. Theranostics for Advanced Prostate Cancer: Current Indications and Future Developments.
Farolfi A; Fendler W; Iravani A; Haberkorn U; Hicks R; Herrmann K; Walz J; Fanti S
Eur Urol Oncol; 2019 Mar; 2(2):152-162. PubMed ID: 31017091
[TBL] [Abstract][Full Text] [Related]
7. PSMA PET and Radionuclide Therapy in Prostate Cancer.
Bouchelouche K; Turkbey B; Choyke PL
Semin Nucl Med; 2016 Nov; 46(6):522-535. PubMed ID: 27825432
[TBL] [Abstract][Full Text] [Related]
8. Prostate-specific membrane antigen regulates angiogenesis by modulating integrin signal transduction.
Conway RE; Petrovic N; Li Z; Heston W; Wu D; Shapiro LH
Mol Cell Biol; 2006 Jul; 26(14):5310-24. PubMed ID: 16809768
[TBL] [Abstract][Full Text] [Related]
9. Identification of alternative protein targets of glutamate-ureido-lysine associated with PSMA tracer uptake in prostate cancer cells.
Bakht MK; Hayward JJ; Shahbazi-Raz F; Skubal M; Tamura R; Stringer KF; Meister D; Venkadakrishnan VB; Xue H; Pillon A; Stover M; Tronchin A; Fifield BA; Mader L; Ku SY; Cheon GJ; Kang KW; Wang Y; Dong X; Beltran H; Grimm J; Porter LA; Trant JF
Proc Natl Acad Sci U S A; 2022 Jan; 119(4):. PubMed ID: 35064078
[TBL] [Abstract][Full Text] [Related]
10. PSMA PET/CT for staging and treatment of prostate cancer.
Hofman M
Clin Adv Hematol Oncol; 2019 Jul; 17(7):370-373. PubMed ID: 31449501
[No Abstract] [Full Text] [Related]
11. PSMA Ligands for Radionuclide Imaging and Therapy of Prostate Cancer: Clinical Status.
Lütje S; Heskamp S; Cornelissen AS; Poeppel TD; van den Broek SA; Rosenbaum-Krumme S; Bockisch A; Gotthardt M; Rijpkema M; Boerman OC
Theranostics; 2015; 5(12):1388-401. PubMed ID: 26681984
[TBL] [Abstract][Full Text] [Related]
12. Selection and characterization of Anticalins targeting human prostate-specific membrane antigen (PSMA).
Barinka C; Ptacek J; Richter A; Novakova Z; Morath V; Skerra A
Protein Eng Des Sel; 2016 Mar; 29(3):105-15. PubMed ID: 26802163
[TBL] [Abstract][Full Text] [Related]
13. Follow-up of Lesions with Equivocal Radiotracer Uptake on PSMA-Targeted PET in Patients with Prostate Cancer: Predictive Values of the PSMA-RADS-3A and PSMA-RADS-3B Categories.
Yin Y; Werner RA; Higuchi T; Lapa C; Pienta KJ; Pomper MG; Gorin MA; Rowe SP
J Nucl Med; 2019 Apr; 60(4):511-516. PubMed ID: 30190303
[TBL] [Abstract][Full Text] [Related]
14. Prostate-Specific Membrane Antigen Targeted Therapy of Prostate Cancer Using a DUPA-Paclitaxel Conjugate.
Lv Q; Yang J; Zhang R; Yang Z; Yang Z; Wang Y; Xu Y; He Z
Mol Pharm; 2018 May; 15(5):1842-1852. PubMed ID: 29608845
[TBL] [Abstract][Full Text] [Related]
15. Cloning and characterization of canine prostate-specific membrane antigen.
Schmidt S; Fracasso G; Colombatti M; Naim HY
Prostate; 2013 May; 73(6):642-50. PubMed ID: 23359458
[TBL] [Abstract][Full Text] [Related]
16. A Novel ¹¹¹In-Labeled Anti-Prostate-Specific Membrane Antigen Nanobody for Targeted SPECT/CT Imaging of Prostate Cancer.
Chatalic KL; Veldhoven-Zweistra J; Bolkestein M; Hoeben S; Koning GA; Boerman OC; de Jong M; van Weerden WM
J Nucl Med; 2015 Jul; 56(7):1094-9. PubMed ID: 25977460
[TBL] [Abstract][Full Text] [Related]
17. Disulfide-constrained peptides that bind to the extracellular portion of the prostate-specific membrane antigen.
Lupold SE; Rodriguez R
Mol Cancer Ther; 2004 May; 3(5):597-603. PubMed ID: 15141017
[TBL] [Abstract][Full Text] [Related]
18. Recombinant glutamate carboxypeptidase II (prostate specific membrane antigen--PSMA)--cellular localization and bioactivity analyses.
Meighan MA; Dickerson MT; Glinskii O; Glinsky VV; Wright GL; Deutscher SL
J Protein Chem; 2003 May; 22(4):317-26. PubMed ID: 13678295
[TBL] [Abstract][Full Text] [Related]
19. Advances in prostate-specific membrane antigen PET of prostate cancer.
Bouchelouche K; Choyke PL
Curr Opin Oncol; 2018 May; 30(3):189-196. PubMed ID: 29465429
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and Evaluation of Multifunctional Fluorescent Inhibitors with Synergistic Interaction of Prostate-Specific Membrane Antigen and Hypoxia for Prostate Cancer.
Kwon YD; Oh JM; La MT; Chung HJ; Lee SJ; Chun S; Lee SH; Jeong BH; Kim HK
Bioconjug Chem; 2019 Jan; 30(1):90-100. PubMed ID: 30485073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
